Investors are getting ready to revisit emerging markets

Emerging market equities have fallen for most of 2022. But an improving regulatory outlook in China and Russia’s removal from major benchmark indices are reattracting investor attention, suggesting that any early optimism may have been delayed, not derailed.

The MSCI Emerging Markets Index has followed global stocks lower this year, losing nearly a fifth of its value year to date (YTD). After underperforming against world indices in three of the previous four years, emerging market (EM) equities were positioned for a recovery at the start of 2022. At the time, hope stemmed from distressed market valuations and rising Covid-19 vaccine inoculation rates.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media